2009
DOI: 10.1080/14767050902994622
|View full text |Cite
|
Sign up to set email alerts
|

Increased visfatin and leptin in pregnancies complicated by pre-eclampsia

Abstract: These findings suggest that increased maternal levels of leptin and visfatin may be involved in the pathogenesis of pre-eclampsia, and measurement of these adipokines may be useful in assessment of the severity of disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
42
1

Year Published

2009
2009
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 48 publications
(45 citation statements)
references
References 29 publications
2
42
1
Order By: Relevance
“…Many studies have shown that visfatin may play an important role in placentation for normal pregnancy, although its role has not been clearly determined (42)(43)(44)(45). In this respect we can consider the possibility that administered visfatin during superovulation contributes to improved fertility potential by positively affecting normal placentation.…”
Section: Discussionmentioning
confidence: 94%
“…Many studies have shown that visfatin may play an important role in placentation for normal pregnancy, although its role has not been clearly determined (42)(43)(44)(45). In this respect we can consider the possibility that administered visfatin during superovulation contributes to improved fertility potential by positively affecting normal placentation.…”
Section: Discussionmentioning
confidence: 94%
“…Thus visfatin has been reported to cause upregulation of pro-inflammatory and pro-contractile cytokines [26].The visfatin gene (in amnion epithelial cells) is also upregulated in response to inflammatory stimuli and stretch, suggesting a role in pre-tem labour [56]. Pregnancy and infection-associated preterm labour are associated with increased levels of visfatin, and visfatin or leptin changes have been reported in pregnancies complicated by preeclampsia, foetal growth restriction and gestational diabetes mellitus [24][25][26]28,29,31,[57][58][59][60]. However, direct extrapolation of the effects of circulating or local visfatin on labour onset and delivery need further data and in vivo studies.…”
Section: Discussionmentioning
confidence: 95%
“…14 Previous studies reviewed the contribution of visfatin/NAMPT in PE. 15 Most findings provide evidence for increased circulating visfatin levels [16][17][18][19][20] in patients with PE, although decreased serum visfatin levels 21 or visfatin expression have also been reported in PE. 22 Moreover, other studies found no differences in circulating visfatin levels when normal pregnant were compared with patients with PE.…”
Section: Introductionmentioning
confidence: 94%